News | November 29, 2021
Bharat Biotech commences export of Covaxin
It’s a two-dose vaccine administered 28 days apart
It’s a two-dose vaccine administered 28 days apart
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
Acute therapies continue to report strong growth compared to chronic ones.
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
It is a recombinant nanoparticle protein-based vaccine
_256_384.jpg)
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
Filing for WHO Emergency Use Authorisation this month
Subscribe To Our Newsletter & Stay Updated
